Home > Financial Ratios > LASA SUPERGENERICS

LASA SUPERGENERICS
Core EBITDA Growth

    Back to All Ratios
LASA SUPERGENERICS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for LASA SUPERGENERICS
Please provide your vote to see the results

LASA SUPERGENERICS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 148.85-129.21-65.6056.89160.58

What is the latest Core EBITDA Growth ratio of LASA SUPERGENERICS ?

The latest Core EBITDA Growth ratio of LASA SUPERGENERICS is 148.85 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar2024148.85
Mar2023-129.21
Mar2022-65.60
Mar202156.89
Mar2020160.58

How is Core EBITDA Growth of LASA SUPERGENERICS Trending?

Years Core EBITDA Growth % Change
Mar2024 148.85
Positive
Mar2023 -129.21
Negative
Mar2022 -65.6
Negative
Mar2021 56.89
-64.57
Mar2020 160.58 -

Other Financial Ratios of LASA SUPERGENERICS


Compare Core EBITDA Growth ratio of peers of LASA SUPERGENERICS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LASA SUPERGENERICS ₹56.7 Cr -3.3% -1.7% -61.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,287.0 Cr -0.6% 4% -6.4% Stock Analytics
DIVIS LABORATORIES ₹177,657.0 Cr -1.7% 9.3% 12.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,202.0 Cr 5.2% 7% 11.9% Stock Analytics
CIPLA ₹122,276.0 Cr 0.1% 1.3% -5.1% Stock Analytics
DR REDDYS LABORATORIES ₹100,024.0 Cr 0.2% -2.9% -4.9% Stock Analytics


LASA SUPERGENERICS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LASA SUPERGENERICS

-3.3%

-1.7%

-61.1%

SENSEX

-0.5%

2%

4.8%


You may also like the below Video Courses